128.60CHF-1.53%Mkt Cap: —P/E: 49.051d ago
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools f…
Industry Peers
Healthcare$1.14TUSDP/E 43.0
$658.89BUSDP/E 31.7
$462.68BUSDP/E 74.0
$345.19BUSDP/E 24.7
$375.50BUSDP/E 122.7
$348.81BUSDP/E 25.0
$283.47BUSDP/E 22.7
$276.41BUSDP/E 23.7
$234.02BUSDP/E 25.0
$240.45BUSDP/E 24.5
$238.75BUSDP/E 27.4
$226.85BUSDP/E 33.1
$190.75BUSDP/E 11.3
$198.81BUSDP/E 36.9
$183.02BUSD
$160.96BUSDP/E 37.2
$142.58BUSDP/E 38.5
$151.78BUSDP/E 38.6
$142.49BUSDP/E 45.6
$130.23BUSDP/E 32.1
Key Statistics
Company
Market Cap—
Enterprise Value3.27B $
Revenue (TTM)780.45M $
Gross Profit523.47M $
Net Income (TTM)108.95M $
Revenue/Share39.17 USD
Last Price128.60 CHF
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees2.0K
CountryGB
SectorHealthcare
Industry—
ISINCH0468525222
Valuation
P/E (Trailing)49.05
P/E (Forward)—
PEG—
EV/EBITDA16.65
EV/Revenue4.19
P/S—
P/B6.08
EPS (TTM)2.62
EPS (Forward)—
52W Range
128.600% of range132.60
52W High132.60 CHF
52W Low128.60 CHF
Profitability
Gross Margin67.07%
Oper. Margin15.96%
EBITDA Margin25.13%
Profit Margin13.96%
ROE22.83%
ROA8.40%
Growth
Revenue Growth12.50%
Earnings Growth1.20%
Cash Flow & Leverage
Operating CF174.22M $
CapEx (TTM)—
FCF Margin-4.91%
FCF Yield—
Net Debt261.99M $
Net Debt/EBITDA1.34
Balance Sheet
Debt/Equity57.55
Current Ratio2.08
Quick Ratio0.77
Book Value/Sh21.73 CHF
Cash/Share1.668 CHF
Dividends
Fwd Div Rate—
Trail. Div Rate1.181 CHF
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.0
Float6.00M
Insiders69.66%
Institutions15.26%
Technical
SMA 50127.76 (+0.7%)
SMA 200120.71 (+6.5%)
Beta0.98
S&P 52W Chg20.80%
Avg Vol (30d)5.33K
Avg Vol (10d)673
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—